Controlled Release Drug Delivery Market Size, Share, Competitive Landscape and Trend Analysis Report, by Technology Outlook and, by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

Controlled release drug delivery is the dosage form that delivers a drug or medication in a predetermined manner. This system of drug delivery provides continuous delivery of drugs or medication in predictable kinetics for the predetermined time in the whole course of gastrointestinal transit. The drug is released until it reaches a specific target in the GI tract. Systems of control release drug delivery employ drug encapsulating devices from which the drug or medication is released at a rate that is controlled for a significantly long period, ranging from days to months.

COVID-19 Scenario Analysis

• The high prevalence of the infection is likely to grow in the market because of the need for long hours of medication for the treatment of the coronavirus. This factor is likely to boost the controlled release drug delivery market.
• The consequences of lockdown and government-enforced restrictions as a result of the coronavirus pandemic have, of course, been felt heavily by businesses across all industries. Both the private healthcare sector and health and which rely on close physical contact with their clients have been significantly affected. 
• Many small hospitals, dermatology clinics and nursing homes have been forced to shut their operations. The result of social distancing and localized curfews have resulted in delayed procedures. In addition, visa cancellations have led to a hiatus in medical tourism and can negatively impact the healthcare services market growth. The current outbreak of the COVID-19 has negatively impacted the manufacturing sector.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Advantages of controlled release drug delivery systems are such as lower dose requirement, improved stability of the drug, minimum side effects, improved drug efficacy and safety, higher bioavailability and enhanced patient compliance. Additionally, rising awareness about the benefits regarding the controlled release drug delivery system as compared to conventional drug delivery systems is likely to prop up the market.
Controlled release drug delivery also enables reduction of the dose which minimizes the risk of overdose in elderly people. Dysphagia for geriatric people or unpleasant taste of pediatric drugs or medication is to act as fuel for adopting the system of controlled release drug delivery. Complicated manufacturing procedures and strict government regulations are factors that are likely to slow the growth of controlled release drug delivery in the forecast timeline.

The targeted drug delivery system is predicted to hold the major share in the market as the huge number of market players have a strong technological portfolio. Key drivers in the market are the rise in the number of ANDA & NDA applications, increase in research and development expenditure and techniques, presence of core market players, growing patient pool with diseases like diabetes requiring prolong treatment, rise in demand for controlled-release medications. The Asia-Pacific market is expected to grow rapidly due to the growing geriatric population, high population growth and rapidly growing pharmaceutical companies. Additionally, the rising focus of key players for expanding the business due to low manufacture costs is likely to grow the market of controlled release drug delivery in the Asia-Pacific.

Key Benefits of the Report

• This study presents the analytical depiction of the global controlled release drug delivery market along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global controlled release drug delivery market share.
• The current market is quantitatively analyzed to highlight the global controlled release drug delivery market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
• The report provides a detailed global controlled release drug delivery market analysis based on competitive intensity and how the competition will take shape in the coming years. 

Questions Answered in the Controlled Release Drug Delivery Market Research Report

• What are the leading market players active in the controlled release drug delivery market?
• What current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?

  Controlled Release Drug Delivery Market Report Highlights

Aspects	Details
By Technology Outlook	Wurster Technique Coacervation Micro Encapsulation Implants Transdermal Targeted Delivery Others
By Application	Metered Dose Inhalers Injectable Transdermal and Ocular Patches Infusion Pumps Oral Controlled-drug Delivery Systems Drug Eluting Stents
By Region	North America  (U.S, Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd., Bayer HealthCare LLC, GE Healthcare, APOLLO RT Co. Ltd., VIVID IMAGING, Sino Medical-Device Technology Co., Ltd, Medtron AG, Bracco Group

Related Tags

• Controlled Release Drug Delivery